Bristol Myers Squibb Employees Begin Cross-Country Bike Ride in Support of Cancer Research

PRINCETON, N.J. — Bristol Myers Squibb employees are set to embark on a cross-country bike ride covering nearly 3,000 miles, aiming to raise over $1 million for the V Foundation for Cancer Research. The event, known as Coast 2 Coast 4 Cancer (C2C4C), has become a significant tradition at Bristol Myers Squibb, with more than 760 employees participating and raising over $9.83 million for cancer research since its inception in 2014.

The 2022 ride, launching today, will see participants cycling from Cannon Beach, Oregon, with the journey concluding on October 3 in Long Branch, New Jersey. The ride is dedicated to honoring loved ones impacted by cancer, and the funds raised will be matched dollar-for-dollar by Bristol Myers Squibb, with a maximum donation of up to $500,000.

Some riders have faced personal battles with cancer, while others are cycling in memory of family and friends affected by the disease. Drew Adams, a Bristol Myers Squibb employee and one of over 126 participants, sees C2C4C as an opportunity to raise awareness for cancer research and honor his uncles who passed away from cancer. For Adams, the ride is also a meditative process to reflect on his own journey with testicular cancer, which he beat during the COVID-19 pandemic.

“I went from receiving a cancer diagnosis on a Wednesday to getting surgery on the following Monday,” says Adams. “Part of this ride is a meditative process for me to think, process, and absorb the experience I’ve been through and be inspired by the beauty of nature to take on this challenge for patients of tomorrow.”

The primary goal of the C2C4C ride is to raise funds for the V Foundation for Cancer Research, a charitable organization dedicated to achieving Victory Over Cancer®. Bristol Myers Squibb’s commitment to the cause is evident in their continued support of cancer research and their employees’ active involvement in the annual ride.

Catherine Owen, Senior Vice President, General Manager of U.S. Cardiovascular, Immunology, and Oncology at Bristol Myers Squibb, stated, “Coast 2 Coast 4 Cancer gives them the opportunity to ride for loved ones impacted by cancer. We are honored, once again, to support the V Foundation to raise funds for research and make a genuine difference in the lives of people living with cancer.”

In addition to the cross-country ride, Bristol Myers Squibb colleagues from Europe, Japan, and Latin America are also participating in various rides to demonstrate their commitment to cancer research. The company’s support extends globally, with rides such as Country 2 Country 4 Cancer Europe, Continent 2 Continent 4 Cancer Japan, and Continent 2 Continent 4 Cancer Latin America.

For more information or to support the riders in the 2022 Coast 2 Coast 4 Cancer ride, please visit cancerbikeride.org or follow the ride on Instagram, Twitter, Facebook, and LinkedIn using #C2C4C22.

About Bristol Myers Squibb Company Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. For more information, visit BMS.com or follow Bristol Myers Squibb on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

About the V Foundation for Cancer Research The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach and ESPN commentator. The V Foundation has funded nearly $290 million in game-changing cancer research grants nationwide through a competitive process strictly supervised by a world-class Scientific Advisory Committee. Because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations are awarded to cancer research and programs. The V team is committed to accelerating Victory Over Cancer®. To learn more, visit v.org.